LEI 9695005FDP4WWUAN6E05

INSTITUT GUSTAVE ROUSSY

Awards tracked

57

Value

€36.4M

Countries

FR

Download sample CSV

Contract awards & public grants

Multispecific theranostic nano-engager platform → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-07-01

€150,000

Advancing Breast cancer Individualised Generative AI for Longitudinal Outcomes → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-06-10

€490,124

Early clinical development of first-in-class EGL-001 targeting Tregs in head and neck squamous cell carcinoma, supported by AI-based pathomics → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-05-21

€975,313

immunoTHErapies targeting neOgenes in paeDiatric and adOlescent saRcomAs → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-05-19

€159,249

Phase I/II trial of an Oral ER-stress iNducer in relapsed/refractory neuroblastoma and paediatric solid tumours → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-05-15

€100,000

ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-05-13

€209,900

Cardio-Oncology Multidisciplinary Patient ASsistance Solution → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2026-03-25

€467,188

Clonal hematopoiesis in cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2025-11-12

€1.5M

Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2025-07-08

€314,669

Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2025-05-15

€1M

Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2025-05-14

€90,019

Specific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-12-11

€626,225

Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-12-05

€434,500

OPTIMAL METHODS TO CHARACTERIZE ADC RESISTANCE IN SOLID TUMORS AND IDENTIFY CLINICALLY USEFUL BIOMARKERS → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-11-07

€3.28M

Microbiota-controlled trafficking of immunosuppressive intestinal T cells into cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-09-13

€2.49M

VHIO International postDoctoral programme for translAtional research → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-09-12

—

Training network for tracking and controlling therapeutic immune cells in cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-07-16

€282,694

Treating Liver Metastasis → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2024-06-11

€2.86M

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean p → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-12-13

—

Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-12-07

€1.82M

A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-12-07

€84,800

Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseases → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-11-17

€1.47M

Training Future Big Data Experts for Europe → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-10-18

—

101155946 - ERN PAEDCAN-Y7-Y10 - EUROPEAN REFERENCE NETWORK ON PAEDIATRIC CANCER → INSTITUT GUSTAVE ROUSSY ASSOCIATION

HADEA - European Health and Digital Executive Agency · FR · Grant · 2023-10-01

€132,680

Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-07-13

—

Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-28

€219,375

Targeting SWI/SNF-related chromatin remodelling defects in solid tumours → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-26

€1.5M

A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMO → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-24

€143,925

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-24

€371,813

First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-24

€2.08M

ECM and TFEB interplay: from building multidisciplinary devices to unravelling the missing link in cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2023-04-21

€195,915

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-12-02

€288,625

An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-11-28

€571,367

Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception. → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-11-24

€2.44M

FCAECC Fellowship programme for talented researchers in cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-10-10

—

Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-07-25

€498,625

101056190 - ALADDIN - MULTI-STAKEHOLDER EDUCATION ALLIANCE TO ACCELERATE DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENT WITH CANCER (ALADDIN) → INSTITUT GUSTAVE ROUSSY ASSOCIATION

EACEA - Education, Audiovisual and Culture Executive Agency · FR · Grant · 2022-06-01

€110,322

THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-05-20

€630,250

Data-driven cancer genome interpretation for personalised cancer treatment → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-05-20

€380,983

Cancer cell plasticity on targeted therapy → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2022-05-16

—

Spermidine in hypertension: therapeutic potential and novel mechanisms → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2021-02-22

€196,708

International Human Microbiome Coordination and Support Action → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2021-01-22

€24,983

Building Data Rich Clinical Trials → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2021-01-18

€73,417

Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2020-06-12

€46,780

Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2020-05-18

€306,239

4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer scre → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2019-12-06

€125,750

Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and auto → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2019-08-30

€120,000

Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2019-05-13

€345,250

Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2019-04-23

€233,784

Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2018-12-03

€2.94M

International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2017-12-05

€534,574

A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2017-11-27

€117,000

Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo plat → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2017-09-12

€688,328

ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2017-05-18

€500,912

Resistance mechanisms to tyrosine kinase inhibitors in solid tumors → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2016-11-28

€1.5M

ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2015-07-31

—

Training Network for the Immunotherapy of Cancer → INSTITUT GUSTAVE ROUSSY

European Commission · FR · Grant · 2015-06-12

€262,876

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.